Hamburg Prioritizes Post-Market Safety, Innovation At Confirmation Hearing
This article was originally published in The Gray Sheet
Executive Summary
FDA Commissioner-designate Margaret "Peggy" Hamburg's top priorities for the agency include fostering technological innovation and improving the safety of medical products through closer post-market monitoring